About Us
Scientists at the University of Geneva have teamed up to address a key challenge in molecular medicine: how to produce gene therapy vectors in an affordable manner? The technology will revolutionize cost and enhance accessibility of gene therapy for those who need it.
Our Story
We are proud to present our team of experts behind the Vectopia project. Dr. Patrick Salmon has been designing and researching gene therapy vectors for more than 20 years. Prof. Karl Krause is an acclaimed expert in translational medicine, having published over 200 articles and created six start-up companies. Dr. Jean-Marc Leroux is a highly accomplished business professional with over 25 years of experience in the life sciences sector, building relationships and driving success. Fabien Abdul, Manon Locatelli, Maude Rolland and Pascale are top quality researchers who complete the team. Together, our team brings the expertise and experience to create innovative gene therapy vector solutions.